World's Best Scientists 2026 revealed!
Trends in Cancer
H-index 60

Trends in Cancer

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 437 111 116 38

Additional Metrics

Number of Best Scientists*: 338
Documents by Best Scientists*: 293
Top 100 Ranked Scientists*: 15
SCIMAGO H-index: 101
SCIMAGO SJR: 4.727
Impact Factor: 17.5

Overview

Top Research Topics at Trends in cancer?

The journal mainly deals with areas of study such as Cancer, Cancer research, Cancer cell, Tumor microenvironment and Immunotherapy. The studies in Cancer featured incorporate elements of Immune system, Immunology, Computational biology and Bioinformatics. The research on Cancer research tackled can also make contributions to studies in the areas of Cell, Cancer stem cell, Metastasis, Tumor progression and Epigenetics.

The studies tackled, which mainly focus on Epigenetics, apply to DNA methylation as well. The in-depth study on Cancer cell also explores topics in the intersecting field of Cell biology. Tumor microenvironment and Angiogenesis are closely related fields of research discussed in it.

It facilitated presentations on Immunotherapy research, particularly Cancer immunotherapy and Immune checkpoint.

  • Cancer (46.95%)
  • Cancer research (42.44%)
  • Cancer cell (17.20%)

What are the most cited papers published in the journal?

  • Hypoxia-Inducible Factors: Master Regulators of Cancer Progression (364 citations)
  • Targeting TGF-β Signaling in Cancer. (358 citations)
  • Surviving at a Distance: Organ-Specific Metastasis (252 citations)

Research areas of the most cited articles at Trends in cancer:

The most cited articles cover a variety of subjects, including Cancer, Cancer research, Immunology, Tumor microenvironment and Immune system. While the journal articles focused on Cancer, they were also able to explore topics like Computational biology, Bioinformatics and Cell biology. While work presented in the published articles provide substantial information on Cancer research, it also covers topics in Chemotherapy, Cancer cell, Metastasis, Radiation therapy and Immunotherapy.

What topics the last edition of the journal is best known for?

  • Cancer
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The discussions in the journal mainly cover the fields of Cancer, Cancer research, Immunotherapy, Immune system and Cell biology. The journal holds forums on Cancer that merges themes from other disciplines such as Cell and Computational biology. It explores issues in Cancer research which can be linked to other research areas like Carcinogenesis, Metastasis, Tumor progression, Cancer therapy and Epigenetics.

The journal explores topics in Immunotherapy which can be helpful for research in disciplines like Microbiome, Gut flora, Programmed cell death and Immunosurveillance. The studies on Immune system discussed can also contribute to research in the domains of Inflammation and Stem cell. In it, Interferon, Downregulation and upregulation, Enzyme, Metabolic reprogramming and DNA repair are investigated in conjunction with one another to address concerns in Cell biology research.

The most cited articles from the last journal are:

  • 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (31 citations)
  • Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy. (17 citations)
  • Extracellular Vesicles in Cancer Detection: Hopes and Hypes. (14 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Trends in cancer (based on the number of publications) are:

  • Lorenzo Galluzzi (8 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Vivek Subbiah (7 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Frédéric Thomas (4 papers) absent at the last edition,
  • Beata Ujvari (4 papers) absent at the last edition,
  • Iannis Aifantis (4 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Trends in cancer (based on the number of publications) are:

  • Harvard University (33 papers) published 8 papers at the last edition, 4 more than at the previous edition,
  • University of Texas MD Anderson Cancer Center (21 papers) published 5 papers at the last edition, 1 less than at the previous edition,
  • National Institutes of Health (21 papers) published 6 papers at the last edition, 5 more than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (17 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Cornell University (15 papers) published 6 papers at the last edition, 5 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.59% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.20% were posted by at least one author from the top 10 institutions publishing in the journal. Another 16.81% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.58% of all publications and 35.40% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Prospects and Pathways for Cancer Researchers and Oncologists

For individuals interested in pursuing a career focused on cancer research, it is important to understand the various pathways and career prospects available. Depending on one's qualifications, interests, and career goals, different trajectories may appeal to different individuals. Some may be interested in becoming researchers, contributing to the understanding and treatment of cancer from a laboratory-based perspective. Others may opt to become oncologists, using their knowledge and skills to treat patients and improve lives. Understanding the different roles and their educational and professional requirements can help prospective individuals to plan their career pathway effectively.

In terms of researching career paths, aspiring cancer researchers can take many routes depending on their interests and skill sets. Some may choose to focus their research on the fields discussed in this article, such as Immunotherapy, Cell biology or Computational biology. Those interested in research in the United States may want to look at programs and positions in top institutions known for their work in cancer research. To become a successful cancer researcher, an advanced degree in a related field, usually a PhD, is required. This is typically followed by a postdoctoral fellowship or a research associate position, before one can lead their own research.

For individuals interested in clinical practice, a career as an oncology nurse or an oncologist can be considered. Oncologists are doctors specialized in diagnosing and treating cancer. It requires a medical degree followed by a residency in oncology. Oncology nurses require a bachelor's degree in nursing followed by certification in oncology nursing. You can understand more about one such pathway by learning how to become a nurse in New Jersey here. The website provides valuable information on how to start the journey of nursing with an emphasis on specializations in cancer care.

Finally, one can combine both these facets and become a clinician-scientist, practicing medicine while also contributing to research in the field. This generally requires a dual degree, such as an MD-PhD.

While the path to a career focussing on cancer can be competitive and challenging, it is rewarding on many levels. The work contributes immensely to improving patients' lives and advancing medical science. It also offers opportunities for lifelong learning, and its interdisciplinary nature opens avenues for collaboration, exploration, and innovation.

Top Publications

  • Glioblastoma Stem Cells: Driving Resilience through Chaos.

    Briana C. Prager;Shruti Bhargava;Vaidehi Mahadev;Christopher G. Hubert

    (2020)
    283 Citations
  • The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View

    Joao B. Xavier;Vincent B. Young;Joseph Skufca;Fiona Ginty

    (2020)
    245 Citations
  • Exosomes as a Multicomponent Biomarker Platform in Cancer.

    Valerie S. LeBleu;Raghu Kalluri

    (2020)
    242 Citations
  • Clinical Development of BRAF plus MEK Inhibitor Combinations.

    Vivek Subbiah;Christina Baik;John M. Kirkwood

    (2020)
    230 Citations
  • MGMT Status as a Clinical Biomarker in Glioblastoma.

    Madison Butler;Lorinc Pongor;Yu-Ting Su;Liqiang Xi

    (2020)
    203 Citations
  • Gut Microbiota in Cancer Immune Response and Immunotherapy

    Cheng-Bei Zhou;Yi-Lu Zhou;Jing-Yuan Fang

    (2021)
    197 Citations
  • Challenges in glioblastoma research: focus on the tumor microenvironment.

    (2022)
    190 Citations
  • The emerging field of oncolytic virus-based cancer immunotherapy.

    (2022)
    156 Citations
  • Antibody-drug conjugates: in search of partners of choice.

    (2023)
    147 Citations
  • Molecular Tumor Boards in Clinical Practice.

    Claudio Luchini;Rita T. Lawlor;Michele Milella;Aldo Scarpa

    (2020)
    126 Citations

Related Online Degrees & Career Pathways

Exploring careers in medicine often involves diverse educational routes that complement or expand clinical expertise. For example, nurses aiming to advance their practice can consider pmhnp online programs, which focus on psychiatric mental health nurse practitioner certification available through flexible online formats.

Similarly, registered nurses looking to deepen their family practice knowledge may benefit from post masters fnp certification programs. These online courses allow nurses who already hold a master's degree to specialize further without the need for a full additional degree.

For those interested in nutrition and preventive health, pursuing an accelerated nutrition degree online offers a way to quickly enter the field with credentials geared toward dietetics and wellness careers.

Furthermore, many RNs looking to enhance their qualifications consider the easiest rn to bsn program options, which provide a streamlined path to obtaining a Bachelor of Science in Nursing. These programs help expand career prospects and are highly compatible with working professionals’ schedules.

Best Scientists Contributing to This Journal

Recently Published Articles